These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10395416)

  • 1. Cost of medications for patients with ischemic heart disease in a rural family practice center.
    Patricoski CT; Steiner G
    J Am Board Fam Pract; 1999; 12(3):200-5. PubMed ID: 10395416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the Medicare modernization act on low-income persons.
    Havrda DE; Omundsen BA; Bender W; Kirkpatrick MA
    Ann Intern Med; 2005 Oct; 143(8):600-8. PubMed ID: 16230727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The patient level cost of asthma in adults in south central Ontario. Pharmacy Medication Monitoring Program Advisory Board.
    Ungar WJ; Coyte PC; Chapman KR; MacKeigan L
    Can Respir J; 1998; 5(6):463-71. PubMed ID: 10070174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between medication supplies and healthcare costs in older adults from an urban healthcare system.
    Stroupe KT; Murray MD; Stump TE; Callahan CM
    J Am Geriatr Soc; 2000 Jul; 48(7):760-8. PubMed ID: 10894314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication utilization in an urban homebound population.
    Kronish IM; Federman AD; Morrison RS; Boal J
    J Gerontol A Biol Sci Med Sci; 2006 Apr; 61(4):411-5. PubMed ID: 16611710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a retrospective database analysis of drug utilization and costs for treatment of chronic hepatitis B virus infection in the northern Netherlands between 2000 and 2006.
    Tu HA; Bos JH; Woerdenbag HJ; Visser ST; Wilschut JC; van Assen S; de Jong-van den Berg LT; Postma MJ
    Clin Ther; 2010 Jan; 32(1):133-44. PubMed ID: 20171419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of implementing a more restrictive prescription limit on Medicaid recipients. Effects on cost, therapy, and out-of-pocket expenditures.
    Martin BC; McMillan JA
    Med Care; 1996 Jul; 34(7):686-701. PubMed ID: 8676607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of asthma medication adherence rates and strategies to improve adherence in the underserved population at a Federally Qualified Health Center.
    Bidwal M; Lor K; Yu J; Ip E
    Res Social Adm Pharm; 2017; 13(4):759-766. PubMed ID: 27595427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk.
    Piette JD; Heisler M; Wagner TH
    Am J Public Health; 2004 Oct; 94(10):1782-7. PubMed ID: 15451750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures.
    Piette JD; Heisler M; Horne R; Caleb Alexander G
    Soc Sci Med; 2006 Feb; 62(4):846-57. PubMed ID: 16095789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of type 2 diabetes medication cost sharing on patient outcomes and health plan costs.
    Thornton Snider J; Seabury S; Lopez J; McKenzie S; Goldman DP
    Am J Manag Care; 2016 Jun; 22(6):433-40. PubMed ID: 27355811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinician identification of chronically ill patients who have problems paying for prescription medications.
    Heisler M; Wagner TH; Piette JD
    Am J Med; 2004 Jun; 116(11):753-8. PubMed ID: 15144912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of over-the-counter medication coverage in the Oregon Medicaid population: the impact on program costs and drug use.
    Zechnich AD; Greenlick M; Haxby D; Mullooly J
    Med Care; 1998 Aug; 36(8):1283-94. PubMed ID: 9708599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization and costs of cardiovascular disease medications in dialysis patients in Medicare Part D.
    Frankenfield DL; Weinhandl ED; Powers CA; Howell BL; Herzog CA; St Peter WL
    Am J Kidney Dis; 2012 May; 59(5):670-81. PubMed ID: 22206743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the Care of Dual Eligible Patients in Rural Federally Qualified Health Centers: The Impact of Care Coordinators and Clinical Pharmacists.
    Doyle D; Emmett M; Crist A; Robinson C; Grome M
    J Prim Care Community Health; 2016 Apr; 7(2):118-21. PubMed ID: 26582045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness].
    Leutgeb R; Mahler C; Laux G; Weschnetz A; Szecsenyi J
    Dtsch Med Wochenschr; 2009 Jan; 134(5):181-6. PubMed ID: 19180404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicians' attitudes about prescribing and knowledge of the costs of common medications.
    Reichert S; Simon T; Halm EA
    Arch Intern Med; 2000 Oct; 160(18):2799-803. PubMed ID: 11025790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.